Skip to content
HowShorted

Twist Bioscience Corp short interest in 2023

In 2023, Twist Bioscience Corp's disclosed short interest ran from 16.10% of shares outstanding on 13 Jan 2023 to 20.24% on 29 Dec 2023, a change of +4.14 percentage points. The year's high was 26.85% on 13 Oct 2023 and its low 16.10% on 13 Jan 2023, averaging 22.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.68 days on 31 Oct 2023. Full history: Twist Bioscience Corp.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Twist Bioscience Corp in 2023

2023 in figures

Start of year
16.10% (13 Jan 2023)
End of year
20.24% (29 Dec 2023)
Change
+4.14 pp
High
26.85% (13 Oct 2023)
Low
16.10% (13 Jan 2023)
Average
22.84%
Highest days to cover
17.68 (31 Oct 2023)
SEC filings marked
8

Every report in 2023

Twist Bioscience Corp short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202316.10%11.09
31 Jan 202316.27%9.93
15 Feb 202316.61%5.29results (8-K), 10-Q filed
28 Feb 202317.60%9.06
15 Mar 202319.45%8.81
31 Mar 202320.96%8.32
14 Apr 202321.26%8.93
28 Apr 202321.75%10.55
15 May 202324.21%7.74results (8-K), 10-Q filed
31 May 202325.72%10.73
15 Jun 202325.63%12.21
30 Jun 202325.86%11.10
14 Jul 202325.08%13.31
31 Jul 202323.48%14.93
15 Aug 202323.84%10.47results (8-K), 10-Q filed
31 Aug 202324.70%15.69
15 Sep 202324.35%12.99
29 Sep 202323.86%15.13
13 Oct 202326.85%16.47
31 Oct 202326.06%17.68
15 Nov 202326.18%15.49
30 Nov 202326.84%11.46results (8-K), 10-K filed
15 Dec 202325.25%7.97
29 Dec 202320.24%8.62

See also: Twist Bioscience Corp's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.